NEW YORK – Tilray Brands, Inc. (NASDAQ:TLRY), a company specializing in medicinal chemicals and botanical products currently trading near its 52-week low, has reached a settlement agreement regarding ...

Aphria Inc. has agreed to pay $30 million to settle a class-action lawsuit by shareholders alleging the company made ...

Tilray Brands settled a multi-year securities class action brought against its subsidiary Aphria and some of its former executives.

Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International cannabis markets.

The next phase will see outdoor cultivation in Cayuga, Ontario this spring. Tilray’s key Canadian facilities, Aphria One and Aphria Diamond, are now fully operational and expected to ...

Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today ...

Aphria Inc. has agreed to pay $30-million to settle a class-action lawsuit by shareholders alleging the company made misrepresentations to capital markets in 2018. The settlement agreement said ...

Brands announced the completion of Phase I of its accelerated growth plan for its cannabis supply chain, which began with ...

Aphria was acquired by Tilray Inc. in 2021. In a regulatory filing, Tilray noted the payment will be primarily funded by an Aphria insurance policy and by the individual defendants. Aphria will fund ...

Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International ...